
What they do:
Regulating the immune system to block cancer & autoimmune diseases
Quick facts:
HQ: Philadelphia, PA, United States
This list has 8 startups and was last updated on Oct 15, 2026. Latest round: EpiVario raised $185K (Oct 13, 2026).

What they do:
Regulating the immune system to block cancer & autoimmune diseases
Quick facts:
HQ: Philadelphia, PA, United States

What they do:
Converting biology into digital molecular maps
Quick facts:
HQ: Philadelphia, PA, United States
Quick facts:
HQ: Philadelphia, PA, United States
Funding:
$56.9M · Equity · Jan 2026
Quick facts:
HQ: Philadelphia, PA, United States
Funding:
$28M · Equity · May 2026
Quick facts:
HQ: Philadelphia, PA, United States
Funding:
$15.1M · Equity · Jun 2026
Quick facts:
HQ: Philadelphia, PA, United States
Funding:
$4M · Options · Jun 2026
Quick facts:
HQ: Philadelphia, PA, United States
Funding:
$2.52M · Equity · May 2026
Quick facts:
HQ: Philadelphia, PA, United States
Funding:
$185K · Debt · Oct 2026
There are 8 startups on this list, last updated on Oct 15, 2026.
None of them shows open roles right now.
By team size: SFA Therapeutics (4 employees) and Biocartesian (2 employees).
Latest rounds: EpiVario — $185K Debt (Oct 2026), Tolerance Bio — $15.1M Equity (Jun 2026), and Peptaris — $4M Options (Jun 2026).